Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04569058 · ClinicalTrials.gov registry record · NA

Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents With ADHD

A NA study of Autism and Attention Deficit Hyperactivity Disorder, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
38
Enrollment target
1
Study location

NCT04569058: Completed NA study of Autism and Attention Deficit Hyperactivity Disorder, sponsored by Massachusetts General Hospital.

NCT04569058 is a NA study of Autism and Attention Deficit Hyperactivity Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04569058, a NA study of Autism and Attention Deficit Hyperactivity Disorder, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

An open label trial to assess the safety and efficacy of transcranial photobiomodulation (tPBM) in improving autistic traits in ADHD youth.

Conditions Studied

Autism Attention Deficit Hyperactivity Disorder

Interventions

  • DEVICE Transcranial Photobiomodulation

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2021-01-14
Est. Completion 2024-10-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04569058

The ClinicalTrials.gov registry entry for NCT04569058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (79% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Photobiomodulation is the first listed.

NCT04569058 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04569058 about?

NCT04569058 is a clinical study titled "Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents With ADHD". An open label trial to assess the safety and efficacy of transcranial photobiomodulation (tPBM) in improving autistic traits in ADHD youth.

What is the current status of trial NCT04569058?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2021-01-14. Estimated completion is 2024-10-31.

What conditions does trial NCT04569058 study?

This clinical trial studies the following conditions: Autism, Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT04569058?

The interventions under investigation include: Transcranial Photobiomodulation (DEVICE).

Who is sponsoring clinical trial NCT04569058?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04569058 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism

All registered trials for this condition

Attention Deficit Hyperactivity Disorder

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.